Taylor Wealth Management Partners Global Blood Therapeutics, Inc. Transaction History

Taylor Wealth Management Partners

$176 Million
Q2 2022

A detailed history of Taylor Wealth Management Partners transactions in Global Blood Therapeutics, Inc. stock. As of the latest transaction made, Taylor Wealth Management Partners holds 27,917 shares of GBT stock, worth $0. This represents 0.51% of its overall portfolio holdings.

Number of Shares

27,917

Previous 29,615 5.73%

Holding current value

Previous $1.03 Million 13.06%

% of portfolio

0.51%

Previous 0.42%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $37,865 - $63,488	-1,698 Reduced 5.73%	27,917 $892,000
Q1 2022 May 11, 2022	SELL	$25.68 - $35.59 $14,688 - $20,357	-572 Reduced 1.89%	29,615 $1.03 Million
Q4 2021 Jan 28, 2022	SELL	$24.9 - $40.26 $843,213 - $1.36 Million	-33,864 Reduced 52.87%	30,187 $884,000
Q3 2021 Oct 26, 2021	SELL	$25.48 - $37.34 $166,104 - $243,419	-6,519 Reduced 9.24%	64,051 $1.63 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $2,174 - $2,909	-67 Reduced 0.09%	70,570 $2.47 Million

Q1 2021 Apr 21, 2021	BUY	$38.94 - $50.85 $245,945 - $321,168	6,316 Added 9.82%	70,637 $2.88 Million
Q4 2020 Feb 02, 2021	BUY	$37.65 - $63.77 $441,408 - $747,639	11,724 Added 22.29%	64,321 $2.79 Million
Q3 2020 Oct 14, 2020	BUY	$52.76 - $74.49 $510,716 - $721,063	9,680 Added 22.56%	52,597 $2.9 Million
Q2 2020 Jul 27, 2020	SELL	$48.73 - $81.82 $106,621 - $179,022	-2,188 Reduced 4.85%	42,917 $2.71 Million
Q1 2020 May 04, 2020	SELL	$41.72 - $87.2 $17,146 - $35,839	-411 Reduced 0.9%	45,105 $2.3 Million
Q4 2019 Jan 30, 2020	SELL	$45.7 - $81.86 $9,597 - $17,190	-210 Reduced 0.46%	45,516 $3.62 Million
Q3 2019 Oct 17, 2019	BUY	$45.35 - $57.91 $41,948 - $53,566	925 Added 2.06%	45,726 $2.22 Million
Q2 2019 Jul 17, 2019	BUY	$52.6 - $63.29 $11,414 - $13,733	217 Added 0.49%	44,801 $2.36 Million
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $8,157 - $10,909	-204 Reduced 0.46%	44,584 $2.36 Million
Q4 2018 Jan 14, 2019	BUY	$31.54 - $46.67 $82,161 - $121,575	2,605 Added 6.18%	44,788 $1.84 Million
Q3 2018 Oct 23, 2018	BUY	$38.0 - $51.1 $62,396 - $83,906	1,642 Added 4.05%	42,183 $1.6 Million
Q2 2018 Jul 27, 2018	SELL	$38.7 - $50.15 $10,642 - $13,791	-275 Reduced 0.67%	40,541 $1.83 Million
Q1 2018 Apr 11, 2018	SELL	$39.6 - $65.9 $318,740 - $530,429	-8,049 Reduced 16.47%	40,816 $1.97 Million
Q4 2017 Feb 01, 2018	BUY	$29.7 - $45.7 $38,610 - $59,410	1,300 Added 2.73%	48,865 $1.92 Million
Q3 2017 Oct 13, 2017	BUY	$25.1 - $31.05 $1.19 Million - $1.48 Million	47,565	47,565 $1.48 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Wealth Management Partners with notifications on news.

Account

Taylor Wealth Management Partners Global Blood Therapeutics, Inc. Transaction History